Sunbed campaigner acknowledged as one of most influential Australians

17 December 2014
Congratulations to MIA’s Community Co-ordinator, Jay Allen, for being acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.
As a former sunbed user, Jay was diagnosed with stage 3 melanoma in 2008 – a diagnosis that changed his life, turning the former truck driver into a passionate advocate to have sunbeds banned across Australia.
“I started the campaign to ban solariums in Australia in December 2008 because I wasn’t aware of the risks involved when I used them. I didn’t want others to go through what I did by exposing themselves to the harm of these dangerous machines, not knowing the risks associated with them.” Jay says. “With this ban, our future generations will reap the benefits.”
By teaming up with Greens Senator Lee Rhiannon, NSW Greens MP Dr John Kaye, and leading health professor at The University of Sydney Professor Simon Chapman, and together with the support of Melanoma Institute Australia, Jay has ensured the banning of solariums got the attention it deserved.
“I’ve had many meetings with politicians all over Australia sharing my messages about the dangers of solarium use, ran petitions, awareness days, etc.” says Jay. “Persistence has been the key and always speaking from the heart about a real issue that is costing many Australians their life.”
Jay started the campaign that saw sunbeds banned initially in NSW and then throughout Australia. He continues to passionately raise awareness of melanoma and funds for a cure. His campaigning has now moved to New Zealand where he has teamed up with melanoma survivors and key organisations to achieve a ban.

Australasian Melanoma Conference AMC2021
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.

Predicting disease spread in thin melanoma
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.

Exploring our own clinical questions through MIA's new trials initiative
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.

Young researchers awarded Fellowships to pursue innovative treatments for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.

Young researchers receive boost to develop innovative treatment for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.

Launch of Melanoma March 2021
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.

WA Melanoma Community Forum
An evening for WA melanoma patients, carers and the wider melanoma community, where speakers will provide updates on melanoma research, treatment and support.

Olivia Vivian announced as MIA ambassador
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.

Melanoma breakthrough - neoadjuvant treatment saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.

Melanoma breakthrough - neoadjuvant therapy saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.

Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.

Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.

A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.

Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.

It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.

Prof Richard Scolyer named Outstanding Cancer Researcher of the Year
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.

Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.

MIA researchers feature on prestigious Highly Cited Researchers 2020 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.

Game On Mole is back this summer!
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.

RCPA recognition for Professor Richard Scolyer.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.